Compounding for women’s health: a compounder’s perspective – need, regulations, and future

Abstract

Compounding medicine involves various health-care professionals working together to produce medications that treat patient conditions including menopause and other women’s health-related illnesses. These medications are compounded under the standards and guidelines mandated by individual state pharmacy boards, the US Food and Drug Administration, and other professional organizations. Contrary to commercial medications, the personalized medicine aspect of compounding medications ensures that the patient’s allergies, doses, and drug delivery preferences are addressed during formulation. In the foreseeable future, compounders will continue to formulate medications that are unavailable in the commercial sector, following strict safe-practice guidelines. More importantly, the application of pharmacogenomics and three-dimensional printing to compounding medications could revolutionize compounding formulations and generate new approaches for personalized medicine.

摘要

混合药物是涉及各种保健专业人员合作生产治疗患者疾病的药物, 包括更年期和其他妇女健康相关疾病。这些药物是根据各州药房委员会、美国食品和药物管理局和其他专业组织规定的标准和指南合成的。与商业药物相反, 配制药物的个性化药物方面确保患者的过敏、剂量和给药偏好在配制过程中得到解决。在可预见的未来, 复方制剂将继续按照严格的安全实践指南配制商业领域无法获得的药物。更重要的是, 药物基因组学和3D打印在药物配制中的应用可能会彻底改变配制配方, 并产生个性化药物的新方法。

Keywords:

• Bioidentical hormones
• compounding
• pharmacy
• menopause
• women’s health

Potential conflict of interest

The authors report no conflict of interest.

Source of funding

Nil.